TJP1 and colitis: Chitosan and its derivatives have also been reported as anti‐inflammatory agents capable of stimulating the expression of the tight junction proteins claudin‐1, occludin, and ZO‐1, and restoring intestinal barrier function in DSS‐induced colitis (J. Wang et al. 2019).